Related Experiment Videos
Hypnotic activity of brotizolam: a study in general practice
British Journal of Clinical Pharmacology
|January 1, 1983
Summary
Brotizolam, a hypnotic medication, significantly improved sleep quality for insomnia patients. Participants reported sleeping better and longer, preferring brotizolam over placebo with no adverse effects.
Area of Science:
- Pharmacology
- Sleep Medicine
- Clinical Trials
Background:
- Insomnia is a prevalent sleep disorder affecting millions globally.
- Effective and safe hypnotic medications are crucial for managing insomnia.
- Brotizolam is a benzodiazepine derivative with known hypnotic properties.
Purpose of the Study:
- To evaluate the hypnotic activity of 0.25 mg brotizolam in general practice.
- To compare brotizolam's efficacy and patient preference against a placebo.
- To assess the tolerability and safety of brotizolam for insomnia treatment.
Main Methods:
- A double-blind, crossover study design was employed.
- Participants aged 18-70 with insomnia complaints were included.
- 0.25 mg brotizolam was administered and compared to placebo.
Main Results:
- Patients reported improved sleep quality, reduced awakenings, and increased sleep duration with brotizolam.
- Overall patient preference favored brotizolam over placebo.
- Subjective well-being assessments were comparable between brotizolam and placebo.
Conclusions:
- 0.25 mg brotizolam demonstrates significant hypnotic activity in patients with insomnia.
- Brotizolam is well-tolerated and preferred by patients compared to placebo.
- Brotizolam offers a safe and effective treatment option for insomnia.